Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Balzarini

Showing results (81-90 of 672) with videos related to

Pageof 68
Sort By:
European Journal of Medicinal Chemistry|February 27, 2007
Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-onesJan Balzarini, Barbara Orzeszko, Jan K Maurin, et al.
Pest Management Science|April 20, 2005
Insecticidal activity of the pyrimidine nucleoside analogue (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU)Michael Breuer, Arnold De Loof, Jan Balzarini, et al.
Plos One|June 7, 2013
Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1Bart Hoorelbeke, Jie Xue, Patricia J LiWang, et al.
Molecular Pharmacology|May 14, 2008
Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug developmentKatrien O François, Joeri Auwerx, Dominique Schols, et al.
Trends in Parasitology|August 2, 2017
Surface Glycans: A Therapeutic Opportunity for Kinetoplastid DiseasesVíctor M Castillo-Acosta, Jan Balzarini, Dolores González-Pacanowska
Antimicrobial Agents and Chemotherapy|September 25, 2003
Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV actionMiguel Stevens, Christophe Pannecouque, Erik De Clercq, et al.
Molecular Pharmacology|January 15, 2004
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitorsJoeri Auwerx, Robert Esnouf, Erik De Clercq, et al.
Antiviral Chemistry & Chemotherapy|October 3, 2003
Synthesis and antiviral activity of some 5'-N-phthaloyl-3'-azido-2',3'-dideoxythymidine analoguesJan Balzarini, Erik De Clercq, Beata Kaminska, et al.
Journal of Medicinal Chemistry|December 3, 2002
A thymidine phosphorylase-stable analogue of BVDU with significant antiviral activitySven Guenther, Jan Balzarini, Erik De Clercq, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivativesMiguel Stevens, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 68

Showing results (81-90 of 672) with videos related to

Sort By:
Pageof 68
European Journal of Medicinal Chemistry|February 27, 2007
Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-onesJan Balzarini, Barbara Orzeszko, Jan K Maurin, et al.
Pest Management Science|April 20, 2005
Insecticidal activity of the pyrimidine nucleoside analogue (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU)Michael Breuer, Arnold De Loof, Jan Balzarini, et al.
Plos One|June 7, 2013
Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1Bart Hoorelbeke, Jie Xue, Patricia J LiWang, et al.
Molecular Pharmacology|May 14, 2008
Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug developmentKatrien O François, Joeri Auwerx, Dominique Schols, et al.
Trends in Parasitology|August 2, 2017
Surface Glycans: A Therapeutic Opportunity for Kinetoplastid DiseasesVíctor M Castillo-Acosta, Jan Balzarini, Dolores González-Pacanowska
Antimicrobial Agents and Chemotherapy|September 25, 2003
Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV actionMiguel Stevens, Christophe Pannecouque, Erik De Clercq, et al.
Molecular Pharmacology|January 15, 2004
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitorsJoeri Auwerx, Robert Esnouf, Erik De Clercq, et al.
Antiviral Chemistry & Chemotherapy|October 3, 2003
Synthesis and antiviral activity of some 5'-N-phthaloyl-3'-azido-2',3'-dideoxythymidine analoguesJan Balzarini, Erik De Clercq, Beata Kaminska, et al.
Journal of Medicinal Chemistry|December 3, 2002
A thymidine phosphorylase-stable analogue of BVDU with significant antiviral activitySven Guenther, Jan Balzarini, Erik De Clercq, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivativesMiguel Stevens, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 68